BT1718 in Patients with Advanced Solid Tumours.

NCT03486730 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Advanced Solid Tumours
Non-Small Cell Lung Cancer
Non-Small Cell Lung Sarcoma
Oesophageal Cancer

Interventions

DRUG: BT1718

Sponsor

Cancer Research UK

Collaborators

[object Object]